A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder

This multicenter, randomized, double-blind, placebo-controlled, active-referenced (duloxetine 60 mg), parallel-group study evaluated the short-term efficacy and safety of vortioxetine (10–20 mg) on cognitive function in adults (aged 18–65 years) diagnosed with major depressive disorder (MDD) who sel...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahableshwarkar, Atul R, Zajecka, John, Jacobson, William, Chen, Yinzhong, Keefe, Richard SE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839526/
https://www.ncbi.nlm.nih.gov/pubmed/25687662
http://dx.doi.org/10.1038/npp.2015.52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839526/
https://www.ncbi.nlm.nih.gov/pubmed/25687662
http://dx.doi.org/10.1038/npp.2015.52

Ejemplares similares